Cart
sales@molnova.com
Home -
Products -
GPCR/G Protein -
Dopamine Receptor -
Gemcitabine monophosphate sodium salt hydrate
Gemcitabine monophosphate sodium salt hydrate
CAS No. 1638288-31-9
Gemcitabine monophosphate sodium salt hydrate( —— )
Catalog No. M18102 CAS No. 1638288-31-9
Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 178 | In Stock |
|
| 25MG | 340 | In Stock |
|
| 50MG | 567 | In Stock |
|
| 100MG | 956 | In Stock |
|
| 200MG | 1474 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGemcitabine monophosphate sodium salt hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
-
DescriptionGemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorAutophagy| DNA| Thymidylate synthase| UMP-CMP kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1638288-31-9
-
Formula Weight405.16
-
Molecular FormulaC9H12F2N3Na2O8P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=c1nc(N)ccn1[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@@H](O)C1(F)F.[Na+].O.[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Miao L, et al.Adv Funct Mater. 2014 Nov 12;24(42):6601-6611. PubMed PMID: 25395922; PubMed Central PMCID: PMC4225819.
molnova catalog
related products
-
Phenelzine
Phenelzine is an antidepressant and mania drug, which is a monoamine oxidase inhibitor. Its antidepressant effect is similar to that of niacinamide.
-
GSK 789472 hydrochlo...
GSK 789472 hydrochloride is both a dopamine D3 receptor antagonist and a D2 partial agonist.
-
UCM-1306
UCM-1306 is a potent and orally active allosteric modulator (PAM) of the human dopamine D1 receptor. It increases the maximal effect of endogenous dopamine (DA) in both human and mouse D1 receptors.
